$AME

BofA names top industrial stocks for second quarter 2026 By Investing.com

BofA Securities named AMETEK, Rockwell Automation, ITT Inc., Forgent Power Solutions, and Innio N.V. as top industrial/multi-industry picks for Q2 2026. BofA cited AMETEK’s 22% YoY organic order growth and a $5B cash deal for Indicor. For ITT, it cited Q1 2026 EPS of $1.98 on $1.2B revenue. Innio: equipment orders $1.22B (+122% YoY) and FY2027 revenue $3.80B, adj. EBITDA $720M.

Original reporting
Published Jul 8, 2026, 6:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 6:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefSector analysis
Primary signal
$AME
Bullish
medium confidence
Mentioned
$AME · $ROK · $ITT
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMEBullishLow
01

Why it matters

The most tradable elements are AMETEK’s disclosed $5B acquisition and ITT’s cited Q1 2026 earnings beat plus order-strength commentary. Other names are driven more by BofA’s expectations and product/platform narratives than by new, confirmed datapoints.

02

Market read

This is a sector pick list with some concrete catalysts (AMETEK deal, ITT earnings figures) but limited evidence of brand-new, market-moving disclosures on the publication date.

03

What to watch

Deal execution risk (AMETEK/Indicor), pricing pushback risk in automation, and whether neocloud demand and FY2027 guidance actually confirm the bullish setup.

Relevance 4/10Novelty 4/10Timing: heading into Q2 2026, with conference and deal/order commentary

Background

BofA Securities published its top industrial and multi-industry stock picks for Q2 2026, citing order momentum, automation demand, and specific corporate actions.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

BofA’s top pick cites AMETEK’s 22% YoY organic order growth and a $5B cash acquisition of Indicor Instrumentation.

Expected impact

Moderately positive bias, with upside skew if order acceleration and deal integration expectations hold.

Evidence & confidence

The article provides specific order growth (22% YoY) and a disclosed $5B acquisition, both actionable catalysts, but lacks new deal timing/financing details.

$ROKBullishLow confidence
Context

BofA highlights Rockwell Automation’s broadening industrial automation demand and new FactoryTalk software platforms.

Expected impact

Slightly positive bias, mainly for positioning around industrial automation demand.

Evidence & confidence

The piece is largely channel-check and product/platform framing, with no new guidance numbers or fresh financial datapoint.

$ITTBullishMedium confidence
Context

BofA notes ITT’s first-quarter 2026 EPS of $1.98 and revenue of $1.2B, plus CEO comments on strong April orders.

Expected impact

Mildly positive, with potential follow-through if investors treat the order strength as durable.

Evidence & confidence

The article includes concrete earnings figures and specific order-demand quotes, but it does not state this is a newly released print today.

Market effects

Supports a constructive read-through for industrials and industrial automation via short-cycle order acceleration and data center demand.

Mentions European defense spending as an opportunity for ITT, implying potential regional demand tailwinds.

Highlights data center demand and defense-related capex themes that can influence broader industrial supply chains.

Counterpoint

BofA’s list is largely thesis-driven (channel checks, modeled growth, and expectations) and may not translate into near-term earnings beats.

Key entities

  • BofA Securities

    Investment bank publishing Q2 2026 industrial stock picks and associated theses.

  • AMETEK

    Announced agreement to acquire Indicor Instrumentation for $5B cash; cited strong order growth.

  • Rockwell Automation

    Launched FactoryTalk software platforms; BofA sees improving short-cycle demand.

  • ITT Inc.

    Reported Q1 2026 EPS and revenue; CEO cited strong April orders and European defense opportunity.

  • Innio N.V.

    IPO in February; BofA initiated coverage with quantified Q2 equipment order expectations.

Related articles

$ITTMed

ITT Inc. Q2 2026 Earnings Call Summary

ITT Inc. reported Q2 2026 results driven by 13% organic revenue growth, including 17% at CCT and 21% at Flow Technologies. Full-year organic revenue guidance was raised to 5% to 8% and margin expansion of over 100 bps is expected. Management cited SPX FLOW integration synergies, $71m one-time acquisition costs, and Middle East order delays.

$ITTMedAI 8/10

ITT Boosts FY26 Outlook; Stock Up 5.4% - Update

ITT, Inc. (ITT) reported Q2 results and raised its FY2026 guidance. It now expects earnings of $4.47 to $4.67 per share and adjusted earnings of $8.12 to $8.32 per share, with revenue growth of 38 to 41% and organic growth of 5 to 8%, versus prior ranges. ITT also declared a $0.386 dividend for Q3 2026. Shares were up about 5.4% premarket.

$ITTMed

ITT (NYSE:ITT) Delivers Impressive Q2 CY2026

ITT Inc. (NYSE:ITT) reported Q2 CY2026 results. Revenue rose 51.5% year on year to $1.47 billion, topping Wall Street estimates by 5.9%. Non-GAAP adjusted EPS was $2.08, up from $1.64, and beat consensus by 6.9%. Analysts expect revenue growth of 20.4% and full-year EPS to rise from $7.69 to $8.43.

$ITTHigh

ITT INC. (ITT): Results of Operations and Financial Condition

ITT INC. (ITT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease2026q2.htm EX-99.1 Document Exhibit 99.1 ITT REPORTS 2026 SECOND QUARTER EARNINGS PER SHARE (EPS) OF $0.95, ADJUSTED EPS OF $2.08 RAISING FULL YEAR GUIDANCE ON REVENUE, MARGIN, EPS AND CASH • 53% order growth, 13% organic, driven by SPX FLOW acquisition a

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.